CEESAY ABRAHAM (Chief Executive Officer) sold 1.5% of their position (8.21K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $328.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/15/2026ACC: 0001193125-26-304786
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-8.21K
Net shares
Net seller
$328.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
8.21K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.48K
Price / share
$39.72
Trade value
$217.71K
% of position
1.0%
7/14/2026
548.03K→542.55K
Common Stock
Direct
Shares
−2.73K
Price / share
$40.57
Trade value
$110.72K
% of position
0.5%
7/14/2026
542.55K→539.82K
Total
Net shares
−8.21K
Net value
-$328.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2026 | S · Sale | −5.48K | $39.72 | $217.71K | 1.0% | 548.03K | 542.55K |
| Common Stock Direct | 7/14/2026 | S · Sale | −2.73K | $40.57 | $110.72K | 0.5% | 542.55K | 539.82K |
| Total | −8.21K | -$328.44K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned81.73K
Common Stock
IndirectShares owned20.73K
Total
102.46K indirect102.46K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 81.73K | Indirect |
| Common Stock | 20.73K | Indirect |
| Total | 102.46K | 102.46K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported